Valentis, Inc. - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Valentis, Inc.. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Valentis, Inc.. The Group's principal activity is to develop products for peripheral arterial disease and is a clinical-stage biotechnology company. The Group focuses on research, preclinical and early stage clinical development of products in several therapeutic areas including cardiovascular disorders, oncology, haematology and immunology. The Group has three product platforms for the development of novel therapeutics namely the gene medicine, GeneSwitch (r) and DNA vaccine platforms. The Gene medicine platform includes a comprehensive array of proprietary nucleic acid delivery systems. GeneSwitch (r) platform controls erythropoietin protein production from an injected gene by orally administered drug. Synthetic vaccine delivery systems provide consistent levels of gene expression and enhance efficiency of plasmid.

Not the Report you are looking for? Click here for more browsing options.

$600/yr | Annual Subscription | Premium Access to more than 150,000 company reports for $600/year**

$59.99/mo | Monthly Subscription | Premium Access to more than 150,000 company reports for $59.99/month**

$39.95 | ALL Reports on this company | Buy all reports for Valentis Inc

$24.95 | Single Price Analysis Report | Buy this Valentis Inc Price Analysis

Set Currency* Argentinian Pesos Australian Dollars Bermudan Dollars Brazilian Reals Canadian Dollars Chilean Pesos Chinese Renmimbi Colombian Pesos Czech Koruni Danish Kroner Dirham Egyptian Pounds Euro Hong Kong Dollars Hungarian Forints Icelandic Kronas Indian Rupees Indonesian Rupiahs Israel Shekels Japanese Yen Jordanian Dinars Korean Won Malaysian Ringgits Mexican Pesos Moroccan Dirhams New Zealand Dollars Norwegian Kroner Pakistan Rupees Peruvian New Sols Philippine Pesos Polish New Zlotys Pounds Sterling Russian Rubles Saudi Riyals Singapore Dollars Slovak Koruni South African Rands Sri Lanka Rupees Swedish Kronor Swiss Francs Taiwanese Dollars Thai Bahts Turkish Liras U.S. Dollars Venezuelan Bolivars Zimbabwe Dollars * If a currency is not selected, the report will be delivered in the local currency of the company ** Premium access limits users to 500 reports per month

Layout and Content of a Typical Report